Minimizing Pathogenic Bacteria, Including Spores, in Indoor Air

Journal of Environmental Health

Volumn 66, Issue 5, 2003, Pages 19-24

  Utrup, Linda J ^b   Werner, Kenneth ^b   Frey, Allan H ^a  

^a Randomline Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PATHOGEN;

AEROSOL; AIR PARTICLE CONTROL; AIR POLLUTION; AIR POLLUTION CONTROL; AMBIENT AIR; ARTICLE; BACILLUS ANTHRACIS; BACILLUS SUBTILIS; BACTERIAL CELL WALL; BACTERIAL SPORE; BACTERIAL STRAIN; ENTEROCOCCUS; ENVIRONMENTAL SANITATION; GRAM POSITIVE BACTERIUM; HEALTH CARE FACILITY; INFECTION PREVENTION; MICROCOCCUS LUTEUS; NONHUMAN; NURSING HOME; OFFICE WORKER; PHYSICS;

AEROSOLS; AIR MICROBIOLOGY; AIR POLLUTANTS; AIR POLLUTION, INDOOR; BACILLUS SUBTILIS; CROSS INFECTION; ELECTROSTATICS; FILTRATION; HUMANS; MICROCOCCUS LUTEUS; PARTICLE SIZE; SPORES, BACTERIAL;

BACILLI; BACILLUS ANTHRACIS; BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); ENTEROCOCCUS; MICROCOCCUS; MICROCOCCUS LUTEUS; NEGIBACTERIA; POSIBACTERIA;

EID: 0344737621     PISSN: 00220892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Abramson, M.A., & Sexton, D. (1999). Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: At what costs? Infection Control and Hospital Epidemiology, 20(6), 408-411.
2. Doern, G.V., Heilmann, K., Huynh, H., Rhomberg, P., Coffman, S., & Brueggemann, A. (2001). Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrobial Agents and Chemotherapy, 45, 1721-1729.
3. Frey, A.H. (1985). Modification of aerosol size distribution by complex electric fields. Bulletin of Environmental Contamination and Toxicology, 34(6), 850-857.
4. Frey, A.H. (1986a). The influence of electrostatics on aerosol deposition. ASHRAE Transactions, 92(Part 1), 55-64.
5. Frey, A.H. (1986b). Reduction of formaldehyde, ammonia, sulfur dioxide and carbon dioxide concentrations in air. Journal of Environmental Sciences, July/August, 57-59.
6. Frey, A.H. (1996). Enhancing contaminant control to mitigate aeroallergies. Annals of Allergy Asthma & Immunology, 77(6), 460-466.
7. Hicks, W.C. (1999). Aerosol technology: Properties, behavior and measurement of airborne particles. New York: Wiley and Sons, Inc.
8. Leu, H.S., Kaiser, D., Mori, M., Woolson, R., & Wenzel, R. (1989). Hospital-acquired pneumonia: Attributable morbidity and mortality. American Journal of Epidemiology, 129, 1258-1267.
9. Rubin, R.J., Harrington, C., Poon, A., Dietrich, K., Greene, J., & Moiduddin, A. (1999). The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerging Infectious Diseases, 5(1), 9-17.
10. Schentag, J.J. (2001). Antimicrobial management strategies for Gram-positive bacterial resistance in the intensive care unit. Critical Care Medicine, 29(4 Suppl.), N100-N107.
11. Tenover, F., Biddle, C., & Lancaster, M. (2001). Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerging Infectious Diseases, 7(2), 327-332.
12. Tsiodras, S., Gold, H., Sakoulas, G., Eliopoulos, G., Wennersten, C., Venkataraman, L., Moellering, R., & Ferraro, M. (2001). Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet, 358, 207-208.
13. Werner, G., Cuny, C., Schmitz, F., & Witte, W. (2001). Methicillin-resistant, quinupristin-dalfopristin-resistant Staphylococcus aureus with reduced sensitivity to glycopeptides. Clinical Microbiology, 39, 3586-3590.